| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 07/31/2003 | US20030144268 Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 07/31/2003 | US20030144267 Novel compounds |
| 07/31/2003 | US20030144262 Heteroaryl and heterocyclic nitrogen ring containing hydrazide compounds useful for treating neurodegenerative disorderes |
| 07/31/2003 | US20030144175 Protease inhibitors |
| 07/31/2003 | US20030143481 Image forming material and ammonium compound |
| 07/31/2003 | US20030143279 Method for preparing microparticles having a selected polymer molecular weight |
| 07/31/2003 | US20030140787 Cucurbiturils and method for binding gases and volatiles using cucurbiturils |
| 07/31/2003 | CA2473796A1 Substituted quinazolin-4-ylamine analogues |
| 07/31/2003 | CA2473510A1 Pyrimidine derivatives as rho-kinase inhibitors |
| 07/31/2003 | CA2473420A1 Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors |
| 07/31/2003 | CA2473392A1 5-ht3 receptor antagonists and methods of use |
| 07/31/2003 | CA2472682A1 Treating stress response with chemokine receptor ccr5 modulators |
| 07/31/2003 | CA2471342A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/30/2003 | EP1330458A1 N-( 1,2,4]triazoloazinyl) thiophenesulfonamide compounds as herbicides |
| 07/30/2003 | EP1330456A2 N8,n13 -disubstituted quino 4,3,2-kl]acridinium salts as therapeutic agents |
| 07/30/2003 | EP1330455A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 07/30/2003 | EP1330292A2 Radioactive member for use in brachytherapy and method of making |
| 07/30/2003 | EP1330248A2 New treatments for restless legs syndrome |
| 07/30/2003 | EP1027348B1 2-(2'-hydroxyphenyl)benzotriazoles used as u.v. stabilisers |
| 07/30/2003 | EP0958296B1 Heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| 07/30/2003 | CN1433419A Triazaspo[5,5]undecane derivatives and drugs containing the same as the active ingredient |
| 07/30/2003 | CN1433418A Agents for improving learning or memory |
| 07/30/2003 | CN1433417A Pyridopyrimidinone derivatives for treatment of neurodegenerative disease |
| 07/30/2003 | CN1433411A Chemical compounds |
| 07/30/2003 | CN1433396A Pharmaceutical compounds |
| 07/30/2003 | CN1432571A Pyridone compound and its prepn process |
| 07/30/2003 | CN1116366C Pyridone-methide azo dyestuffs |
| 07/29/2003 | US6599918 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans |
| 07/29/2003 | US6599908 Fused polycyclic 2-aminopyrimidine derivatives |
| 07/24/2003 | WO2003059913A1 Roh-kinase inhibitors |
| 07/24/2003 | WO2003059884A1 Modulators of lxr |
| 07/24/2003 | WO2003059356A2 Novel anti-infectives |
| 07/24/2003 | WO2003059289A2 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
| 07/24/2003 | WO2003059269A2 Acridone inhibitors of impdh enzyme |
| 07/24/2003 | WO2003047577A3 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 07/24/2003 | WO2003043572A3 Methods and compositions related to irm compounds and toll-like receptor pathways |
| 07/24/2003 | US20030139463 Anticancer agents; antiarthritic agents |
| 07/24/2003 | US20030139462 Antiinflammatory agents; autoimmune disease; antiarthritic agents |
| 07/24/2003 | US20030139442 Congestive heart failure |
| 07/24/2003 | US20030139441 Sulfonamido ether substituted imidazoquinolines |
| 07/24/2003 | US20030139417 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof |
| 07/24/2003 | US20030139412 Gastrointestinal disorders |
| 07/24/2003 | US20030139405 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | US20030139400 Controlling cell differentiation; antiinflammatory agents |
| 07/24/2003 | US20030139399 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 07/24/2003 | US20030139397 Pesticides |
| 07/24/2003 | US20030139393 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants |
| 07/24/2003 | US20030139388 Antiinflammatory agents; osteoporosis |
| 07/24/2003 | CA2472619A1 Fused pyrimidine derivates as rho-kinase inhibitors |
| 07/24/2003 | CA2472470A1 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
| 07/24/2003 | CA2469435A1 Modulators of lxr |
| 07/23/2003 | EP1329451A1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 07/23/2003 | EP1329450A1 Benzodiazepine derivative |
| 07/23/2003 | EP1230240B1 Process and intermediates for the preparation of imidazolidinone alpha v integrin antagonists |
| 07/23/2003 | EP0929528B1 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/23/2003 | EP0775702B1 Novel quinolone- or naphthyridonecarboxylic acid derivative or salt thereof |
| 07/23/2003 | CN1432011A Benzoamide piperidine compounds as substance P antagonists |
| 07/23/2003 | CN1431997A 2-acyl indol derivatives and their use as anti-tumour agents |
| 07/23/2003 | CN1431212A Similar of sulph DCK, its synthesizing method and applications |
| 07/23/2003 | CN1115342C Hypnotic beta-carboline derivatives, process for their prepn. and their use as medicinal products |
| 07/22/2003 | USRE38200 Indole-2,3-dione-3-oxime derivatives |
| 07/22/2003 | US6596869 Reacting cyanoquinuclidine compound with isoamyl nitrite for nitrosation |
| 07/22/2003 | US6596867 Bone disorders |
| 07/22/2003 | US6596863 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 07/22/2003 | US6596751 α-substituted carboxylic acid derivatives |
| 07/22/2003 | US6596746 Cyclic protein tyrosine kinase inhibitors |
| 07/22/2003 | US6596738 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I): |
| 07/22/2003 | US6596731 Substituted imidazo[1,2-A] pyridine derivatives |
| 07/22/2003 | US6596730 Phenyl urea and phenyl thiourea derivatives |
| 07/22/2003 | US6596729 Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors |
| 07/22/2003 | US6596728 A pharmaceutical composition, comprising at least one compound or salt thereof as claimed in claim 1 and a polypeptides with excipients |
| 07/22/2003 | US6596726 Method of inhibiting epidermal growth factor by treating, with an effective inhibiting amount, a mammal, in need thereof inhibit the epidermal growth factor receptor and related receptors and, in particular, their tyrosine kinase enzyme |
| 07/22/2003 | CA2294422C Tartrate salt of a substituted dipeptide |
| 07/22/2003 | CA2239603C Quinolines and quinazolines useful in therapy |
| 07/17/2003 | WO2003057698A2 Spiroazacyclic compounds as monoamine receptor modulators |
| 07/17/2003 | WO2003057697A1 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, the preparation thereof and the application of same in therapeutics |
| 07/17/2003 | WO2003057696A1 Deazapurines and uses thereof |
| 07/17/2003 | WO2003057695A1 1,6 naphthyridines useful as inhibitors of syk kinase |
| 07/17/2003 | WO2003057667A2 Strapped and modified bis (benzimidazole) diamides for asymmetric catalysts and other applications |
| 07/17/2003 | WO2003057254A1 Preventives/remedies for urinary disturbance |
| 07/17/2003 | WO2003057165A2 COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF AMYLOID-β PEPTIDE-RELATED DISORDERS |
| 07/17/2003 | WO2003043979A3 Pharmaceutically active compounds and methods of use thereof |
| 07/17/2003 | WO2003032962A3 Dual action antibiotics |
| 07/17/2003 | WO2003018546A3 Tricyclic pyridin-2-one analogues as ligands for gaba-a receptors |
| 07/17/2003 | WO2002046190A3 Sulfonamido ether substituted imidazoquinolines |
| 07/17/2003 | US20030135049 Preparing camptothecin intermediates |
| 07/17/2003 | US20030135044 Novel gamma secretase inhibitors |
| 07/17/2003 | US20030135043 Novel synthesis and crystallization of piperazine ring-containing compounds |
| 07/17/2003 | US20030134886 Pharmaceutically active compounds |
| 07/17/2003 | US20030134873 8-phenyl-(1,2,4)triazolo(1,5-a)pyridin-2-yl)-benzamide derivatives |
| 07/17/2003 | US20030134863 Preventives/remedies for alzheimer's disease |
| 07/17/2003 | US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus |
| 07/17/2003 | US20030134853 Tetrazolyl- and carbamidosulfonyl-substituted 2-phenyl-1-cycloalkyl -benzimidazoles or -imidazo(4,5b)pyridines that inhibit the RNA-dependent RNA polymerase encoded by Hepatitis C |
| 07/17/2003 | US20030134847 New polycyclic azaindole compounds |
| 07/17/2003 | US20030134843 Invention also relates to the tautomeric forms, and possible enantiomeric and diastereomeric forms of said compounds, to the prodrugs thereof and to their use as PARP inhibitors. |
| 07/17/2003 | US20030134840 Novel compounds |
| 07/17/2003 | US20030134836 Substituted arylamine derivatives and methods of use |
| 07/17/2003 | US20030134827 Lactams or pharmaceutically acceptable salt forms thereof, wherein rings ring B is a 4-8 membered cyclic amide containing from 0-3 additional heteroatoms selected from N, O, and S, which are useful as metalloprotease inhibitors. |
| 07/17/2003 | CA2471760A1 Preventives/remedies for urinary disturbance |
| 07/16/2003 | EP1327631A2 Fused heterocyclic compounds, their production and use as angiotensin II antagonists |